V017-4157 Screening compound: N-[(4-FLUOROPHENYL)METHYL]-1-[1-(2-METHYLPROPYL)-1H-1,3-BENZODIAZOL-2-YL]PIPERIDINE-3-CARBOXAMIDE

V017-4157 Screening compound: N-[(4-FLUOROPHENYL)METHYL]-1-[1-(2-METHYLPROPYL)-1H-1,3-BENZODIAZOL-2-YL]PIPERIDINE-3-CARBOXAMIDE
V017-4157 Screening compound: N-[(4-FLUOROPHENYL)METHYL]-1-[1-(2-METHYLPROPYL)-1H-1,3-BENZODIAZOL-2-YL]PIPERIDINE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-4157
N-[(4-FLUOROPHENYL)METHYL]-1-[1-(2-METHYLPROPYL)-1H-1,3-BENZODIAZOL-2-YL]PIPERIDINE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-4157

Molecular Formula

C24H29FN4O (C24 H29 FN4 O)

Compound Name

N-[(4-FLUOROPHENYL)METHYL]-1-[1-(2-METHYLPROPYL)-1H-1,3-BENZODIAZOL-2-YL]PIPERIDINE-3-CARBOXAMIDE

IUPAC name

n/a

SMILES

CC(C)Cn1c(N(CCC2)CC2C(NCc(cc2)ccc2F)=O)nc2c1cccc2

InChI

InChI=1S/C24H29FN4O/c1-17(2)15-29-22-8-4-3-7-21(22)27-24(29)28-13-5-6-19(16-28)23(30)26-14-18-9-11-20(25)12-10-18/h3-4,7-12,17,19H,5-6,13-16H2,1-2H3,(H,26,30)/t19-/m0/s1

InChI Key

RALXOGMHZNTLOO-IBGZPJMESA-N

MDL Number (MFCD)

MFCD19968683

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

408.52

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.589

Distribution Coefficient, logD

4.586

Water Solubility, LogSw

-4.21

Polar Surface Area

37.779

Acid Dissociation Constant (pKa)

12.07

Base Dissociation Constant (pKb)

5.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

V017-4157 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Nucleic Acid Ligands (8311 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with V017-4157 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-4157?
Check Price and Availability of V017-4157, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-4157 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-4157
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-4157
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-4157 available by request